Skip to main content
Log in

Pankreatitisprophylaxe nach ERCP – Indometacin senkt das Risiko signifikant

Prevention of pancreatitis after ERCP – Indomethacin provides a significant risk reduction

  • Für Sie gelesen
  • Published:
Der Gastroenterologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Loperfido S, Costamagna G (2012) Post-ERCP pancreatitis; risk factors. UpToDate (http://www.uptodate.com/contents/post-ercp-pancreatitis)

  2. Katsinelos P, Fasoulas K, Paroutoglou G (2012) Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis. Endoscopy 44: 53–59

    Article  PubMed  CAS  Google Scholar 

  3. Dumonceau J-M, Andriulli A, Deviere J (2010) European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 42: 503–515

    Article  PubMed  Google Scholar 

  4. Mazaki T, Masuda H, Takayama T (2010) Prophylactic pancreatic stent placement and post-ERCP pancreatitis: asystematic review and meta-analysis. Endoscopy 42: 842–853

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W.-R. Martin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martin, WR. Pankreatitisprophylaxe nach ERCP – Indometacin senkt das Risiko signifikant. Gastroenterologe 7, 336–337 (2012). https://doi.org/10.1007/s11377-012-0683-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-012-0683-9

Navigation